vs
Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and IPG PHOTONICS CORP (IPGP). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($336.6M vs $274.5M, roughly 1.2× IPG PHOTONICS CORP). IPG PHOTONICS CORP runs the higher net margin — 4.8% vs 4.0%, a 0.8% gap on every dollar of revenue. On growth, IPG PHOTONICS CORP posted the faster year-over-year revenue change (17.1% vs 2.2%).
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.
GRDN vs IPGP — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $336.6M | $274.5M |
| Net Profit | $13.5M | $13.3M |
| Gross Margin | 22.7% | 36.1% |
| Operating Margin | 5.3% | 1.2% |
| Net Margin | 4.0% | 4.8% |
| Revenue YoY | 2.2% | 17.1% |
| Net Profit YoY | 46.1% | 69.8% |
| EPS (diluted) | $0.21 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $336.6M | — | ||
| Q4 25 | $397.6M | $274.5M | ||
| Q3 25 | $377.4M | $250.8M | ||
| Q2 25 | $344.3M | $250.7M | ||
| Q1 25 | $329.3M | $227.8M | ||
| Q4 24 | — | $234.3M | ||
| Q3 24 | $314.4M | $233.1M | ||
| Q2 24 | — | $257.6M |
| Q1 26 | $13.5M | — | ||
| Q4 25 | $20.9M | $13.3M | ||
| Q3 25 | $9.8M | $7.5M | ||
| Q2 25 | $9.0M | $6.6M | ||
| Q1 25 | $9.4M | $3.8M | ||
| Q4 24 | — | $7.8M | ||
| Q3 24 | $-122.0M | $-233.6M | ||
| Q2 24 | — | $20.2M |
| Q1 26 | 22.7% | — | ||
| Q4 25 | 21.5% | 36.1% | ||
| Q3 25 | 19.8% | 39.5% | ||
| Q2 25 | 19.8% | 37.3% | ||
| Q1 25 | 19.5% | 39.4% | ||
| Q4 24 | — | 38.6% | ||
| Q3 24 | 19.4% | 23.2% | ||
| Q2 24 | — | 37.3% |
| Q1 26 | 5.3% | — | ||
| Q4 25 | 7.7% | 1.2% | ||
| Q3 25 | 4.3% | 3.1% | ||
| Q2 25 | 3.7% | 0.0% | ||
| Q1 25 | 3.9% | 0.8% | ||
| Q4 24 | — | 6.0% | ||
| Q3 24 | -33.3% | -108.7% | ||
| Q2 24 | — | 4.7% |
| Q1 26 | 4.0% | — | ||
| Q4 25 | 5.3% | 4.8% | ||
| Q3 25 | 2.6% | 3.0% | ||
| Q2 25 | 2.6% | 2.6% | ||
| Q1 25 | 2.9% | 1.6% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | -38.8% | -100.2% | ||
| Q2 24 | — | 7.8% |
| Q1 26 | $0.21 | — | ||
| Q4 25 | — | $0.30 | ||
| Q3 25 | — | $0.18 | ||
| Q2 25 | — | $0.16 | ||
| Q1 25 | — | $0.09 | ||
| Q4 24 | — | $0.27 | ||
| Q3 24 | — | $-5.33 | ||
| Q2 24 | — | $0.45 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $64.9M | $839.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $232.4M | $2.1B |
| Total Assets | $426.9M | $2.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $64.9M | — | ||
| Q4 25 | $65.6M | $839.3M | ||
| Q3 25 | $36.5M | $870.4M | ||
| Q2 25 | $18.8M | $899.6M | ||
| Q1 25 | $14.0M | $926.9M | ||
| Q4 24 | — | $930.2M | ||
| Q3 24 | $37.2M | $1.0B | ||
| Q2 24 | — | $1.1B |
| Q1 26 | — | — | ||
| Q4 25 | $0 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $34.3M | — | ||
| Q2 24 | — | — |
| Q1 26 | $232.4M | — | ||
| Q4 25 | $217.9M | $2.1B | ||
| Q3 25 | $195.5M | $2.1B | ||
| Q2 25 | $179.7M | $2.1B | ||
| Q1 25 | $163.2M | $2.1B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | $133.9M | $2.1B | ||
| Q2 24 | — | $2.3B |
| Q1 26 | $426.9M | — | ||
| Q4 25 | $412.7M | $2.4B | ||
| Q3 25 | $390.0M | $2.4B | ||
| Q2 25 | $356.3M | $2.4B | ||
| Q1 25 | $334.0M | $2.3B | ||
| Q4 24 | — | $2.3B | ||
| Q3 24 | $348.0M | $2.4B | ||
| Q2 24 | — | $2.5B |
| Q1 26 | — | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.26× | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.1M | $28.8M |
| Free Cash FlowOCF − Capex | — | $10.9M |
| FCF MarginFCF / Revenue | — | 4.0% |
| Capex IntensityCapex / Revenue | — | 6.5% |
| Cash ConversionOCF / Net Profit | 0.45× | 2.17× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-3.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $6.1M | — | ||
| Q4 25 | $34.6M | $28.8M | ||
| Q3 25 | $28.2M | $35.3M | ||
| Q2 25 | $19.9M | $-2.2M | ||
| Q1 25 | $17.6M | $13.4M | ||
| Q4 24 | — | $73.8M | ||
| Q3 24 | — | $66.1M | ||
| Q2 24 | — | $53.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $10.9M | ||
| Q3 25 | $24.2M | $14.6M | ||
| Q2 25 | — | $-17.6M | ||
| Q1 25 | — | $-11.4M | ||
| Q4 24 | — | $50.6M | ||
| Q3 24 | — | $43.0M | ||
| Q2 24 | — | $29.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.0% | ||
| Q3 25 | 6.4% | 5.8% | ||
| Q2 25 | — | -7.0% | ||
| Q1 25 | — | -5.0% | ||
| Q4 24 | — | 21.6% | ||
| Q3 24 | — | 18.4% | ||
| Q2 24 | — | 11.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 6.5% | ||
| Q3 25 | 1.1% | 8.3% | ||
| Q2 25 | — | 6.1% | ||
| Q1 25 | — | 10.9% | ||
| Q4 24 | — | 9.9% | ||
| Q3 24 | — | 9.9% | ||
| Q2 24 | — | 9.4% |
| Q1 26 | 0.45× | — | ||
| Q4 25 | 1.65× | 2.17× | ||
| Q3 25 | 2.87× | 4.73× | ||
| Q2 25 | 2.21× | -0.34× | ||
| Q1 25 | 1.86× | 3.58× | ||
| Q4 24 | — | 9.44× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 2.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRDN
Segment breakdown not available.
IPGP
| Materials Processing | $232.8M | 85% |
| Laser And Non Laser Systems | $38.8M | 14% |
| Transferred Over Time | $5.3M | 2% |
